Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Appointed CFO
Quarterly results
Director departure
Appointed director
Notes underwriting agrmnt
Acq. announced
CC transcript

INTERLEUKIN GENETICS INC (ILIU) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2017 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
08/04/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/04/2017 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/04/2017 25 Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities:
07/24/2017 8-K Quarterly results
07/03/2017 8-K Form 8-K - Current report
05/12/2017 4 Toutain Stephan (Chief Commercial Officer) has filed a Form 4 on INTERLEUKIN GENETICS INC
05/11/2017 10-Q Quarterly Report for the period ended March 31, 2017
05/01/2017 10-K/A Annual Report for the period ended December 31, 2016 [amend]
04/18/2017 10-K/A Annual Report for the period ended December 31, 2016 [amend]
04/17/2017 10-K Annual Report for the period ended December 31, 2016
04/03/2017 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
04/03/2017 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
04/03/2017 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
04/03/2017 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
03/31/2017 8-K Form 8-K - Current report
01/26/2017 4 KORNMAN KENNETH S (President and CSO) has filed a Form 4 on INTERLEUKIN GENETICS INC
01/26/2017 4 Carbeau Mark B (CEO) has filed a Form 4 on INTERLEUKIN GENETICS INC
01/26/2017 4 WEAVER JAMES M (Director) has filed a Form 4 on INTERLEUKIN GENETICS INC
01/26/2017 4 Mills William C. III (Director) has filed a Form 4 on INTERLEUKIN GENETICS INC
01/26/2017 4 Toutain Stephan (Chief Commercial Officer) has filed a Form 4 on INTERLEUKIN GENETICS INC
01/05/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
12/27/2016 CT ORDER Form CT ORDER - Confidential treatment order
12/23/2016 8-K Form 8-K - Current report
11/15/2016 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
11/15/2016 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
11/15/2016 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
11/14/2016 10-Q Quarterly Report for the period ended September 30, 2016
11/07/2016 4/A Carbeau Mark B (CEO) has filed a Form 4 on INTERLEUKIN GENETICS INC
10/24/2016 8-K Submission of Matters to a Vote of Security Holders
10/21/2016 4 Carbeau Mark B (CEO) has filed a Form 4 on INTERLEUKIN GENETICS INC
10/21/2016 4 Toutain Stephan (Chief Commercial Officer) has filed a Form 4 on INTERLEUKIN GENETICS INC
10/11/2016 SC 13D/A Delta Dental Plan of Michigan, Inc. reports a 4.8% stake in Interleukin Genetics, Inc.
09/30/2016 RW Form RW - Registration Withdrawal Request
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy